Pediatrix Medical Group, Inc. $MD Shares Bought by SummerHaven Investment Management LLC

SummerHaven Investment Management LLC grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 92.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 111,299 shares of the company’s stock after acquiring an additional 53,534 shares during the period. Pediatrix Medical Group accounts for 2.0% of SummerHaven Investment Management LLC’s investment portfolio, making the stock its 5th biggest holding. SummerHaven Investment Management LLC’s holdings in Pediatrix Medical Group were worth $2,864,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Global Retirement Partners LLC purchased a new stake in shares of Pediatrix Medical Group during the second quarter worth $33,000. Nykredit A S acquired a new stake in Pediatrix Medical Group during the second quarter valued at $35,000. Integrated Wealth Concepts LLC acquired a new stake in Pediatrix Medical Group during the second quarter valued at $53,000. EverSource Wealth Advisors LLC boosted its position in Pediatrix Medical Group by 77.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,515 shares of the company’s stock valued at $54,000 after purchasing an additional 1,100 shares during the last quarter. Finally, Fortitude Family Office LLC grew its stake in Pediatrix Medical Group by 2,239.3% in the third quarter. Fortitude Family Office LLC now owns 2,082 shares of the company’s stock valued at $54,000 after purchasing an additional 1,993 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

MD stock opened at $27.32 on Friday. The firm has a 50 day moving average of $26.45 and a two-hundred day moving average of $24.70. Pediatrix Medical Group, Inc. has a 12 month low of $16.02 and a 12 month high of $28.02. The company has a market capitalization of $2.22 billion, a price-to-earnings ratio of 13.07 and a beta of 0.61. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.45.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The business had revenue of $487.78 million for the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. Pediatrix Medical Group’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.53 EPS. As a group, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 2.17 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on MD. UBS Group upped their target price on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Truist Financial raised their price target on Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $25.00 price target on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Finally, Jefferies Financial Group cut Pediatrix Medical Group from a “buy” rating to a “hold” rating and boosted their price target for the company from $27.00 to $28.00 in a research note on Wednesday, August 19th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $26.60.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc provides physician-led health care services to hospitals, health systems and patients across the United States. The company focuses on specialized care for women, infants and children, supporting patients in hospital-based and affiliated clinical settings.

Its services include neonatal and perinatal care, maternal-fetal medicine, pediatric cardiology and other pediatric subspecialties. Pediatrix physicians commonly practice in neonatal intensive care units, delivery rooms, pediatric emergency departments and other hospital departments, working with care teams to manage complex medical needs.

The company was founded in 1979 and operated for many years under the name MEDNAX, Inc It adopted the Pediatrix Medical Group name in 2023 as part of a broader effort to emphasize its pediatric, neonatal and maternal-fetal health care businesses.